Bruce Salzberg, MD, Gastroenterology, Suwanee, GA, Emory Saint Joseph's Hospital of Atlanta

BruceAndrewSalzbergMD

Gastroenterology Suwanee, GA

Atlanta Gastroenterology Specialists PC

Dr. Salzberg is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Salzberg's full profile

Already have an account?

Education & Training

  • VA Medical CenterFellowship, Gastroenterology, 1982 - 1984
  • Jackson Memorial Hospital - Jackson Health SystemResidency, Internal Medicine, 1979 - 1982
  • State University of New York Upstate Medical UniversityClass of 1979
  • State University at BuffaloB.A., 1972 - 1975
  • State College at OneontaNo Degree, 1971 - 1972

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1987 - 2021
  • MD State Medical License
    MD State Medical License 1983 - 1985
  • FL State Medical License
    FL State Medical License 1981 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
  • Phi Beta Kappa 1979
  • Fellow (FACG) American College of Gastroenterology
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial  
    Bertagnolli, M., Salzberg, B., et al, Cancer Prevention Research Journal, 1/1/2009
  • Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis  
    Baumgart, D., Salzberg, B., et al, Inflammatory Bowel Diseases, 1/1/2009
  • APC Study Investigators Celecoxib for the prevention of sporadic colorectal adenomas  
    Bertagnolli, M., Salzberg, B., et al, New England Journal of Medicine, 1/1/2006
  • Join now to see all

Abstracts/Posters

  • Safety of Infliximab in Crohn�s Disease Data from the TREAT Registry.
    Lichtenstein, G., Salzberg, B., Cohen,R., et al, UEGW, Prague, Czech Republic, 1/1/2004
  • Successful One Hour Infusion of Infliximab for Crohn�s Disease Patients in an Outpatient Setting.
    Salzberg, B., Kendall , K., DDW, 1/1/2004
  • A Humanized Anti-CD3 Monoclonal Antibody, Visilizumab, for Treatment of Severe Steroid-Refractory Ulcerative Colitis: Preliminary results of a Phase I Study
    Plevy, S., Salzberg, B., Regueiro, M., Sandborn, W., Hanauer, S., Targan, S., Mayer, L., Lowder, J., DDW, Orlando, FL, 1/1/2003
  • Join now to see all

Lectures

  • Remicade Therapy �Transcending conventional therapy in Crohn�s Disease Patients" 
    Multiple Locations, 2003, 2004, 2005, 2007 - 1/1/2007
  • Crohn�s Disease State of the Art 
    Tokyo, Japan - 1/1/2002
  • Ulcerative Colitis �The American Way� 
    Istanbul, Turkey - 1/1/2001
  • Join now to see all

Other

  • Delivering patient care the American way (brochure) 
    Salzberg B, Progressing the Management of Ulcerative Colitis
    1/1/2001

Professional Memberships

Hospital Affiliations